INPP4B and metabolic dysfunction-associated steatotic liver disease: Similar to the mouse liver, hepatic INPP4B expression in patients with NAFLD was significantly reduced compared to healthy controls (GSE126848)38 and there was a highly significant correlation between steatosis score and INPP4B mRNA levels (Fig. 4h, i).